News

Hanmi Pharmaceutical will take Aptose Biosciences private, acquiring all outstanding shares it does not already own for C$2.41 in...

Cytomed Therapeutics has completed the acquisition of TCB-002, an allogeneic gamma delta T cell technology from TC BioPharm’s subsidiary,...

Harrow has closed its acquisition of Melt Pharmaceuticals, bringing a portfolio of non-opioid, non-intravenous sedation candidates built on Zydis...

Inotiv posted preliminary fourth-quarter fiscal 2025 revenue of $137.5–$138.5 million and full-year revenue of $512.5–$513.5 million, anchored by continued...

Kraig Biocraft Laboratories has secured a confidential pilot order to supply next‑generation recombinant spider silk yarns to a global...

Protext Mobility has signed a letter of intent with TruLeaf to pair TruLeaf’s nanotechnology with Protext’s extraction platform and...

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion in cash, adding a first-in-class proximity-based small...

NRx Pharmaceuticals has refiled its abbreviated new drug application for Ketafree, a preservative‑free intravenous ketamine, received FDA feedback indicating...

Immatics has moved its PRAME franchise into a pivotal phase, with a global, randomized Phase 3 trial (SUPRAME) of...

Avadel’s board has deemed H. Lundbeck’s unsolicited bid to acquire the company a superior proposal to its existing deal...